Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 151 - 160 of 204 Results.

Time to Do Away with the FDA
Abigail R. Hall | Commentary | Dec. 14, 2015
Hillary on Drugs: Bad Prescription
John R. Graham | Commentary | Oct. 15, 2015
The Drinking Age: Won’t Someone Think of the Children?!
Abigail R. Hall | Commentary | Oct. 10, 2015
A Market-Based Alternative to the $750 Pill
John C. Goodman | Commentary | Oct. 2, 2015
An Excuse for Crushing Kratom
K. Lloyd Billingsley | Commentary | July 24, 2015
Federal Cannabis Standards Are Irrational
Dominick T. Armentano | Commentary | May 23, 2015
New DEA Rule Leaves Patients in Pain
Abigail R. Hall | Commentary | May 15, 2015
How To Get A Drug Company to Give You an Experimental Drug and Other Health Care Updates
John C. Goodman | Commentary | May 13, 2015
Intellectual Property Rights for Global Health
John R. Graham | Commentary | Apr. 30, 2015
Dear FDA, Step Aside So We Might Live
Benjamin Powell | Commentary | Apr. 14, 2015






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL